Impact of Medication Adherence on Health-Related Quality of Life in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study

Background

Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder in young women, marked by hormonal imbalances, insulin resistance, and elevated androgens. Each of these factors causes medical conditions such as obesity and dyslipidemia, and they have a negative effect on social relationships, mental and physical health, and HRQoL.

Materials and Methods

This study was carried out at the Vivekananda General Hospital, Hubballi, Karnataka. Study included 83 female volunteers with PCOS diagnoses between the ages of 18 and 35. Age, marital status, and employment were demographic data gathered. The Medication Adherence Rating Scale (MARS) was used to assess medication adherence.

Results

According to the results of the study, the average HRQOL score among single women with PCOS was 3.514±0.870, and there was no significance (p=0.524) between HRQOL and MARS scores. The mean HRQOL score of married individuals was marginally lower at 3.387±0.788, and there was no significance (p=0.180) between them. Psychological and emotional status and body image showed variation among respondents across HRQOL areas. The study emphasized how different sociodemographic variables and clinical traits impact the complicated nature of HRQOL in PCOS patients.

Conclusion

although PCOS has a substantial negative influence on HRQOL, medication adherence does not seem to be a major factor in determining these results in this research population. To provide more individualized and efficient treatment plans, future studies should examine other variables affecting PCOS patients' HRQOL.